Advertisement

Topics

Latest "Forest Laboratories, Inc. and Clinical Data, Inc." News Stories

23:28 EDT 21st June 2018 | BioPortfolio

Here are the most relevant search results for "Forest Laboratories, Inc. and Clinical Data, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Forest Laboratories, Inc. and Clinical Data, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Forest Laboratories, Inc. and Clinical Data, Inc. for you to read. Along with our medical data and news we also list Forest Laboratories, Inc. and Clinical Data, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Forest Laboratories, Inc. and Clinical Data, Inc. Companies for you to search.

Showing "Forest Laboratories Clinical Data" News Articles 1–25 of 37,000+

Thursday 21st June 2018

Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13

DUBLIN- June 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of the MiniMed(TM) 670G system in patients with type 1 diabetes seven years of age and older. This newest system by Medtronic features the company's most advanced SmartGuard(TM) technology and most accu...


GNTbm announces licensing of exclusive sales/marketing rights of anticancer drug Chidamide to Taiwan Specialty Pharma Corp. (TSPC)

TAIPEI, Taiwan, June 22, 2018 /PRNewswire/ -- GNT Biotech & Medicals Co., Ltd. (GNTbm, TPEx Emerging: 7427) announced that it has awarded exclusive sales and marketing rights in Taiwan of anticancer drug Chidamide to pharmaceutical distribution company Taiwan Specialty Pharma Corp. (TSPC) for two indications; hormone receptor-positive, HER-2 negative late stage breast cancer in post-menopausal...

[Comment] Personalised recovery after general and gynaecologic surgery

Over the past decade, attention on post-surgical recovery has increased. Enhanced recovery pathways have been developed that focus on improving clinical outcomes such as complications and length of stay after major abdominal surgery. Despite their effectiveness, these pathways do not extend beyond discharge and sometimes fail to incorporate patient-reported outcome measures.1 Recovery periods afte...


MAGE-A-Targeted Immunotherapy Competitor Analysis 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Competitor Analysis: MAGE-A-Targeted Immunotherapy” report has been added to ResearchAndMarkets.com’s offering. This Competitive Intelligence report analyzes the competitive field of MAGE-A-Targeted Immunotherapies as of June 2018 in a tabulated format with structured listings of industry-relevant data. Melanoma Associated … Continue ...

automation, programmable instruments, application software, data acquisition, high speed tests, virtual instruments

Designer of, computer software, and hardware, used to, measure and, automate the, collection of, data

separations technology, analytical laboratory, laboratory separations, analytical gas systems, clinical diagnostics, bioprocessing

Manufacturer,of,separations,technology,laboratory,separations,analytical,gas,systems,clinical,diagnostics,bioprocessing,medical,filtration,microplates,molecular,biology

AngelMD Introduces Premium Membership for Investors and Physicians

New $79 subscription service for active investors enables access to exclusive data, events, and discounts. SEATTLE (PRWEB) June 21, 2018 Today AngelMD announced the rollout of its new subscription service known as AngelMD Premium. AngelMD Premium is a $79 monthly subscription that provides a combination of tools intended for investors and physicians who are interested in investing or leading inve...

Concordia Care Presents Effective Patient-Centered Treatment for Post-Traumatic Stress Disorder, Validates Impact on Work Performance at Florida RIMS

June 19 - 23, 2018, The Ritz-Carlton, Naples, FL Concordia Care, Inc. (Concordia), a specialty risk-transfer and care coordination company, announces its presentation, “Effective Patient-Centered Treatment for Post-Traumatic Stress Disorder Impacts Work Performance,”

U.S. Food and Drug Administration (FDA) Accepts Application for Opdivo Plus Low-Dose Yervoy for Treatment of First-Line Non-Small Cell Lung Cancer in Patients with Tumor Mutational Burden ≥10 mut/Mb

First-ever application for an I-O/I-O combination in lung cancer to be accepted Submission based on positive results from Part 1 of the Phase 3 study CheckMate -227 Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) h

Dr. Heidi Jannenga Honored with APTA’s Marilyn Moffat Leadership Award

Dr. Jannenga to be formally recognized for her distinguished contributions to physical therapy at APTA’s NEXT Conference and Exposition WebPT is delighted to announce that Dr. Heidi Jannenga, PT, DPT, ATC/L, co-founder and president of WebPT, has been named the recipient of the prestigious 2018 Marilyn Moffat Leadership Award, which honors ind...

Revance Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia

- RT002 Injectable has potential to be first long-acting neuromodulator for treatment of a debilitating involuntary muscle movement disorder - Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and therapeutic conditions, today announced initiation of patient dosing in the company...

Ironwood Pharmaceuticals Initiates Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease

– Program Designed to Support U.S. Regulatory Filing of IW-3718 as Potential Treatment for Patients Who Continue to Suffer From GERD Despite Receiving Standard of Care – Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced the initiation of two

Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology

New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced U.S. Food and Drug Administration (FDA) approval of the t:slim X2™ Insulin Pump with Bas...

2018 Survivin-Targeted Immunotherapy Competitor Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Competitor Analysis: Survivin-Targeted Immunotherapy” report has been added to ResearchAndMarkets.com’s offering. This Competitive Intelligence report analyzes the competitive field of Survivin-Targeted Immunotherapies as of May 2018 in a tabulated format with structured listings of industry-relevant data. The intracellular … Continue...

NY-ESO-1-Targeted Immunotherapy Competitor Analysis 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Competitor Analysis: NY-ESO-1-Targeted Immunotherapy” report has been added to ResearchAndMarkets.com’s offering. This Competitive Intelligence report analyzes the competitive field of NY-ESO-1-Targeted Immunotherapies as of June 2018 in a tabulated format with structured listings of industry-relevant data. The New … Continue reading ...

Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins” report has been added to ResearchAndMarkets.com’s offering. This report provides a compilation of the sales data of originator recombinant therapeutic proteins and antibodies in the calendar year 2017. … Continue reading → Cet article Blockb...

Review Helps Clinicians Understand Dental Implant Complications

Peri-implantitis is a serious inflammatory condition that can cause extensive bone loss in dental implant patients. In a new study published in the Journal of Oral Implantology, researchers conduct a systematic review of scientific journal articles on peri-implantitis to better understand how to detect and treat the condition. LAWRENCE, Kan. (PRWEB) June 21, 2018 Journal of Oral Implantology – ...

Trastuzumab Duocarmazine Active in HER2-Positive Breast Cancer

The HER2-targeting antibody-drug conjugate (vic-)trastuzumab duocarmazine (SYD985) showed promising clinical activity in heavily-pretreated women with metastatic breast cancer.

Registered direct offering nets $20mm for Compugen

Compugen Ltd. netted $20mm through a registered direct offering of 5.3mm ordinary shares at $3.95 (a 4% premium). Investors a...

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

  NANOBIOTIX ANNOUNCES POSITIVE PHASE II/III TOPLINE DATAIN SOFT TISSUE SARCOMA WITH NBTXR3 Trial achieved its primary endpoint of pathological Complete Response Rate Trial achieved its secondary endpoint in operability (R0 rate) NBTXR3 demonstrated significant superiority and clinical benefits for patients versus standard of care

Vertex’s Paul Negulescu Awarded the Warren Alpert Foundation Prize for Pioneering Discoveries in Cystic Fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named one of the winners of this year’s Warren Alpert Foundation Prize for “transformative discoveries in the fields of genetics, physiology, pulmonology and pharmacology that led to the development of life-altering precision-targeted t...

#news #biotech ‘Big data’ analysis links herpes virus to Alzheimer’s development

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ‘Big data’ analysis links herpes virus to Alzheimer’s development .A “multi-omic” analysis of more than 900 donor brains linked the amount of herpesvirus in a person’s brain to … Continue reading → Cet article #news #biotech R...

MD Magazine® Expands Strategic Alliance Partnership Program with the Addition of NYU Langone Health

The collaboration will help improve patient care through education and research MD Magazine®, a leading online and print source of physician news, conference coverage and peer-to-peer discussion, adds NYU Langone Health to its Strategic Alliance Partnership (SAP) program, announced Michael J. Hennessy Jr., president of MJH Associates, Inc., parent ...

Few Receive All High-Priority Clinical Preventive Services

THURSDAY, June 21, 2018 -- Only 8 percent of U.S. adults aged 35 years and older receive all high-priority clinical preventive services, according to a report published in the June issue of Health Affairs. Amanda Borsky, Dr.P.H., from the Agency for...

NOCDURNA® (desmopressin acetate) Now Approved by U.S. FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria

Clinical trials demonstrated an average reduction of nighttime voids of 52% in women and 43% in men relative to mean baseline (reduction of 1.5 and 1.3 voids respectively)1 NOCDURNA sublingual tablets dissolve rapidly and have specific dosing designed for men and women to deliver a low and effective dose of desmopressin1 ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks